For laboratory and research use only. Not for human consumption. Sold only to qualified researchers.
For Research Use Only. Everything on this page is intended solely for laboratory, analytical, or institutional research — not for human or veterinary use, consumption, diagnosis, treatment, or prevention.

Compound research overview

Tesamorelin COA & Research Overview

A sourced summary of what published literature has studied about Tesamorelin, and what its Certificate of Analysis is actually verifying. This page describes published research; it is not a recommendation, dosing guide, or claim about effects in humans.

Reviewed by Shane Straight, M.S., Principal Chemist at Bioviridian

DAAVY Research Tesamorelin laboratory research vial

1. What Tesamorelin is

Tesamorelin is a synthetic 44-amino acid analog of growth-hormone-releasing hormone (GHRH). It is typically supplied here as a lyophilized (freeze-dried) powder for laboratory use, code-labeled by milligram amount. A tesamorelin formulation is separately marketed as an FDA-approved prescription drug; that approved pharmaceutical product is distinct from this unapproved research-material listing, and no claims of pharmaceutical equivalence, safety, or efficacy are made for this listing.

2. Published literature

This page does not summarize biological findings, outcomes, or mechanisms. Peer-reviewed publications on Tesamorelin can be located through PubMed. The identity, labeled amount, and analytical results for the DAAVY Research listing are documented in its Certificate of Analysis.

3. Scope of this page

  • This page is educational. It documents the identity and analytical testing of a laboratory research material.
  • No claims are made about efficacy, safety, or suitability for any use.
  • For laboratory research use only. Not for human or veterinary use.

4. What a Tesamorelin Certificate of Analysis verifies

Because Tesamorelin is a large (44-amino acid) synthetic peptide supplied as a lyophilized powder, the analytical questions a COA should answer are: does the vial contain the labeled peptide (identity, typically via LC-MS/MS), how much is present relative to the labeled amount (content, via HPLC quantitation), and how pure is the sample (overall purity, via RP-HPLC). See the Interactive COA Decoder for a field-by-field walkthrough and red-flag checklist, and the How to Read a COA guide for the fundamentals.

Sources

Primary literature is available through PubMed and PMC; search by compound name.

Research-use disclaimer

This page summarizes published literature for educational purposes. It has not been evaluated by the U.S. Food and Drug Administration. DAAVY Research supplies Tesamorelin only for legitimate laboratory, analytical, academic, or institutional research; it is not intended for human or veterinary use, consumption, diagnosis, treatment, or prevention. Nothing on this page is dosing, medical, or legal advice. See our complete research-use policy.